期刊文献+

重视肝移植受者的长期生活质量 被引量:5

下载PDF
导出
摘要 随着肝移植手术技术和围手术期处理的日趋成熟以及新型免疫抑制药物的研发,移植术后长期生存率亦逐渐提高,因此如何加强和规范肝移植病人术后的中、长期管理,关注和提高他们的生活质量是我们面临的又一挑战,需关注以下几个方面。
出处 《外科理论与实践》 2008年第4期303-305,共3页 Journal of Surgery Concepts & Practice
  • 引文网络
  • 相关文献

参考文献9

  • 1赵辉,陆敏强,蔡常洁,杨扬,许赤,李华,易述红,易慧敏,汪根树,陈规划.肝移植术后乙肝病毒再感染的危险因素及对策[J].中华肝胆外科杂志,2007,13(1):25-27. 被引量:3
  • 2Herrero JI, Lorenzo M, Quiroga J, et al. De Novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival [J]. Liver Transpl,2005,11(1): 89-97.
  • 3陈规划.加强术后中长期管理,改善和提高我国肝移植受者的长期生存质量[J].中华肝胆外科杂志,2006,12(5):289-291. 被引量:9
  • 4Yoo HY, Thuluvath PJ. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation [J]. Transplantation,2002,74(7): 1007-1012.
  • 5McAlister VC, Peltekian KM, Malatjalian DA, et al. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus[J]. Liver Transpl,2001,7(8):701-708.
  • 6Cvetkovic M, Mann GN, Romero DF, et al. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo [J]. Transplantation, 1994,57(8): 1231 - 1237.
  • 7Yao FY, Gautam M, Palese C, et al. De novo malignancies following liver transplantation: a case-control study with long-term follow-up[J]. Clin Transplant,2006,20(5): 617-623.
  • 8Patapis P, Irani S, Mirza DF, et al. Outcome of graft function and pregnancy following liver transplantation[J]. Transplant Proc,1997,29(1-2):1565-1566.
  • 9Hsu HT, Hwang SL, Lee PH, et al. Impact of liver donation on quality of life and physical and psychological distress[J]. Transplant Proc,2006,38(7):2102-2105.

二级参考文献7

  • 1Samuel D, Muller R, Alexander G, et al. Liver transplantationin European patients with the hepatitis B surface antigen. N Engl J Med, 1993, 329.. 1842-1847.
  • 2Perrillo RP, Wright T, Rakela J, et al. A multieenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology, 2001, 33:424-432.
  • 3Marcellin P, Samuel D, Areias J, et al. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end stage liver disease Hepatology, 1994, 19:6-15.
  • 4Steinmuller T, Seehofer D, Rayes N, et al. Increasing applicability of liver transplantation for patients with hepatitis B related liver disease Hepatology, 2002, 35:1528-1535.
  • 5Seehofer D, Raues N, Steinmuller T, et al. Combination prophylaxis with hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of preatransplant lamivudine resistane. Z Gastroenterol, 2002, 40: 795-799.
  • 6Han SH, Martin p, Edelstein M, et al. Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-termprophylaxis to prevent hepatitis B recurrence after liver transplantation. Liver Transpl, 2003, 9: 182-187.
  • 7Sousa JM, Pareja F, Serrano J, et al. Comparison between levels of anti-HBs with a fixed administration dose of HBIg and a combination of HBIg and lamivudine for the prophylaxis of hepatitis B after liver transplantation. Transplant Proc, 2003, 35: 723-724.

共引文献10

同被引文献53

引证文献5

二级引证文献44

;
使用帮助 返回顶部